NDC 73207-302 – Romvimza
Vimseltinib 14 mg/1 · Capsule · Oral
Product NDC73207-302
Product details
- Brand name
- Romvimza
- Generic name
- Vimseltinib
- Labeler
- Deciphera Pharmaceuticals, LLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA219304
- Marketed since
- February 14, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Vimseltinib 14 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 73207-302-40 | 1 CARTON in 1 CARTON (73207-302-40) / 1 BLISTER PACK in 1 CARTON / 8 CAPSULE in 1 BLISTER PACK | Feb 14, 2025 |
| 73207-302-41 sample | 1 CARTON in 1 CARTON (73207-302-41) / 1 BLISTER PACK in 1 CARTON / 4 CAPSULE in 1 BLISTER PACK | Feb 14, 2025 |